Clearstead Advisors, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Clearstead Advisors, LLC
- $6.44 Billion
- Q4 2024
A detailed history of Clearstead Advisors, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 60 shares of ARCT stock, worth $1,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 20
200.0%
Holding current value
$1,007
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
168Shares Held
26MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$78.8 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$44.5 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$34.7 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$34.7 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$32.5 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $446M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...